zip, the settlement must address the differences between the indications in a way the benefits AMRN or they are done in the US when talking brand name product. If the settlement doesn't address infringement, a big selloff is coming. Hopefully the recent uptick in volume is based on knowledge and not speculation of the contents of settlement.